31,092 results match your criteria: "Aortic Regurgitation"

Objective: To evaluate the results of treatment of postoperative complications in one surgical center over 10 years.

Material And Methods: There were 100 patients with intrapleural complications and indications for surgical correction after various cardiothoracic interventions between 2013 and 2023.

Results: Mortality after thoracoscopic surgeries for cardiothoracic complications was 5%.

View Article and Find Full Text PDF

Uncommon presentation of bacteremia: A case study on aortic valve endocarditis.

SAGE Open Med Case Rep

December 2024

Department of Graduate Medical Education, Internal Medicine Residency Program, Sutter Roseville Medical Center, Roseville, CA, USA.

, a HACEK organism, is one of five species known to less commonly cause infective endocarditis. This article presents a rare and noteworthy case of endocarditis affecting the aortic valve, seemingly unique when species in endocarditis were previously known to more commonly involve the pulmonic or mitral valves. In the setting of bacteremia, a 61-year-old male with no significant past medical history exhibited subtle systemic symptoms with a paucity of clinical signs associated with endocarditis and no evidence of embolic disease.

View Article and Find Full Text PDF

Management of acute decompensated valvular heart disease.

Eur J Heart Fail

December 2024

Department of Medicine I, LMU University Hospital, LMU Munich, Munich, Germany and DZHK (German Center for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany.

Worldwide, valvular heart disease (VHD) is a common cause of hospitalization for acute heart failure. In acute heart failure caused by VHD, symptoms result from rapid haemodynamic changes and subsequent decline in cardiac function, and if left untreated, leads to acute decompensation and cardiogenic shock. Current evidence remains scarce and recommendations regarding the management of acute heart failure caused by VHD are lacking in most recent international guidelines.

View Article and Find Full Text PDF

Transcatheter Edge-to-Edge Repair in Patients With Complex Tricuspid Valve Anatomy.

JACC Cardiovasc Interv

December 2024

University of Virginia, Charlottesville, Virginia, USA. Electronic address: https://twitter.com/psorajja.

Article Synopsis
  • Untreated severe tricuspid regurgitation (TR) is linked to poor health outcomes, making effective treatment essential.
  • The study evaluated the 1-year results of transcatheter edge-to-edge repair (TEER) using the TriClip system in patients with complex tricuspid valve issues, finding significant improvements in patient survival and quality of life.
  • Results showed that 81% of patients experienced a reduction in TR to moderate or less after one year, with no major adverse effects noted in the first 30 days post-procedure.
View Article and Find Full Text PDF

Purpose: Left chest robotic left internal thoracic artery (LITA) to left anterior descending (LAD) coronary revascularization has been established. We hereby describe robotic aortic valve replacement and coronary artery bypass via a right lateral approach.

Description: A 73-year-old female with severe aortic insufficiency, 70% LAD stenosis, and ejection fraction of 35% presents with recalcitrant symptoms.

View Article and Find Full Text PDF

Objectives: The bicuspid aortic valve (BAV) is the most common congenital heart defect. Patients with BAV frequently develop aortopathy, which depends on the dysfunction and morphotype of the BAV.

Aim: The aim of our study was to compare the echocardiography and cardiac magnetic resonance (CMR) findings in BAV patients, and to define the risks of BAV dysfunction and aortopathy.

View Article and Find Full Text PDF

Background: Congenital heart defects (CHD) being the most common congenital malformation, significantly impact mortality and morbidity in children and adults. Early detection greatly improves treatment and prognosis. Routine pulse oximetry screening and fetal echocardiography in Germany have advanced early CHD diagnosis.

View Article and Find Full Text PDF

Introduction: Left ventricular assist device (LVAD) therapy may lead to an aortic regurgitation, limiting left ventricular unloading and causing adverse events. Whether concomitant aortic valve replacement may improve outcomes in patients with preoperative mild-to-moderate aortic regurgitation remains unclear.

Methods: A retrospective propensity score-matched analysis of adult patients with preoperative mild-to-moderate aortic regurgitation undergoing durable LVAD implantation between 01/01/2011 and 30/11/2021 was performed.

View Article and Find Full Text PDF

Cardiovascular magnetic resonance imaging (CMR) has received extensive validation for the assessment of valvular heart disease (VHD) and offers an accurate and direct method for the quantification of aortic regurgitation (AR). According to the current guidelines, CMR represents a useful second-line investigation in patients with poor acoustic windows or when echocardiography is inconclusive, for example, in cases of multiple or eccentric aortic jets. Without ionizing radiation exposure, CMR provides in-depth information not only on the severity degree of AR, providing a precise quantification of regurgitant volume and fraction, but also on cardiac structure and function, being recognized as the gold standard for the assessment of heart chamber size and systolic function.

View Article and Find Full Text PDF

Introduction: The template method (TM), pioneered by Ozaki for aortic valve neocuspidization (AVNeo), has been widely adopted for aortic valve replacement, though it requires specialized instruments. This study introduces a novel formula method (FM), which uses the diameter of the aortic valve fibrous ring (AV-D) to determine the dimensions of the neocusps to be trimmed from autologous without the need for templates, potentially reducing costs and complexity. We aimed to compare the clinical outcomes of the FM with the established TM in patients undergoing AVNeo.

View Article and Find Full Text PDF

Pre-operative left atrial size and functions are predictors of left atrial reverse remodelling after mitral valvuloplasty for myxomatous mitral valve disease in dogs.

J Vet Cardiol

November 2024

Laboratory of Veterinary Internal Medicine, Department of Veterinary Clinical Sciences, Graduate School of Veterinary Medicine, Hokkaido University, N18 W9, Sapporo, Hokkaido 060-0818, Japan.

Objectives: The objective of this study was to determine alterations in left atrial size, function, and determinants of left atrial reverse remodelling (LARR) after mitral valvuloplasty (MVP) in dogs with myxomatous mitral valve disease.

Animals: Thirty-seven dogs undergoing MVP were included in this study.

Materials And Methods: Echocardiographic parameters, including left atrial (LA) strain, were evaluated at baseline, during the early postoperative period (within two weeks), and at one and three months postoperatively.

View Article and Find Full Text PDF

Background: To evaluate short- and long-term outcomes of aortic valve (AV) intervention by decalcification or replacement for the treatment of mild/moderate calcific AV stenosis (AS) in patients undergoing transaortic septal myectomy for subaortic left ventricular outflow tract (LVOT) obstruction.

Methods: Between 2000 and 2023, we identified 137 consecutive patients undergoing myectomy with or without membranectomy for mild to moderate calcific AS. Of these, 93 received surgical intervention on the AV and formed the primary cohort; 44 patients who did not undergo AV intervention were used as a control group.

View Article and Find Full Text PDF

Introduction: Mitral regurgitation is a potential complication of transcatheter aortic valve replacement. Here, we report a case of severe acute mitral regurgitation caused by papillary muscle rupture occurring 16 days after transcatheter aortic valve replacement.

Presentation Of Case: An 82-year-old woman with severe AS was referred to our hospital.

View Article and Find Full Text PDF
Article Synopsis
  • The study examined differences in echocardiographic assessments of native and bioprosthetic aortic valves between core laboratories and clinical centers, finding clinically relevant discrepancies.
  • Data was collected from the PERIGON trial, which involved patients undergoing surgical aortic valve replacement, and involved comparing echocardiographic results from centers to independent analysis by a core lab.
  • Results showed that while some continuous measurements had high agreement (around 0.90), there were notable variances, particularly in left ventricular outflow tract area and stroke volume, indicating the need for standardized evaluation practices.
View Article and Find Full Text PDF
Article Synopsis
  • Takayasu's Arteritis (TA) is a rare and chronic condition affecting large blood vessels, which can result in serious heart problems and potentially life-threatening situations.
  • A 34-year-old woman with a heart murmur experienced chest pain, and imaging revealed multiple cardiac issues leading to her diagnosis of TA.
  • The case emphasizes the importance of early detection and multimodal imaging for patients with unusual symptoms and heart-related complications, especially those with valvular diseases.
View Article and Find Full Text PDF
Article Synopsis
  • There is currently no FDA-approved dedicated transcatheter heart valve specifically for treating native aortic regurgitation.
  • Ongoing clinical trials and compassionate use experiences in the U.S. offer some outcomes data, focusing on echocardiographic and clinical results one year post-procedure.
  • A case study of a 28-year-old man treated with the J-Valve in 2019 shows promising long-term (5-year) outcomes, suggesting it could be a viable minimally invasive option for high-risk patients.
View Article and Find Full Text PDF